Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Atlantic Equities Downgrades Moody’s to Neutral

Atlantic Equities analyst Simon Clinch downgrades Moody's (NYSE:MCO) from Overweight to Neutral.

byBenzinga Newsdesk

June 8, 2022

1 minute read

Atlantic Equities analyst Simon Clinch downgrades Moody’s (NYSE:MCO) from Overweight to Neutral.

Amgen Reaffirms FY21 Guidance; Sees Sales $25.8B-$26.6B vs $26.04B Est., Sees Adj. EPS $16-$17 vs $16.34 Est.

By Bill Haddad

Today, 10:35 AM

2021 total revenues guidance reaffirmed at $25.8-$26.6 billion; EPS guidance revised to $8.84-$9.90 on a GAAP basis, and reaffirmed at $16.00-$17.00 on a non-GAAP basis.

AMGN

President Biden Says Deeply Disappointed By Supreme Court’s Ruling On Concealed Handguns

By Benzinga Newsdesk

Today, 10:35 AM

-Reuters

OLN

Beyond Air Presents Study Update From At-Home LungFit Go Pilot Study For Nontuberculous Mycobacterial Lung Disease At The American Thoracic Society International Conference 2022

By Benzinga Newsdesk

Today, 10:35 AM

Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022 A total of 2,323

XAIR

United States Cellular Q2 EPS $0.39 Down From $0.78 YoY, Sales $1.01B Beat $1.01B Estimate; FY21 Service Sales $3.05B-$3.15B, Adj. EBITDA $1.025B-$1.125B

By Benzinga Newsdesk

Today, 10:35 AM

United States Cellular (NYSE:USM) reported quarterly earnings of $0.39 per share. This is a 50 percent decrease over earnings of $0.78 per share from the same period last year. The company reported quarterly sales of

USM

Atlantic Equities Downgrades Moody’s to Neutral

Related Posts

Amgen Reaffirms FY21 Guidance; Sees Sales $25.8B-$26.6B vs $26.04B Est., Sees Adj. EPS $16-$17 vs $16.34 Est.

President Biden Says Deeply Disappointed By Supreme Court’s Ruling On Concealed Handguns

Beyond Air Presents Study Update From At-Home LungFit Go Pilot Study For Nontuberculous Mycobacterial Lung Disease At The American Thoracic Society International Conference 2022

United States Cellular Q2 EPS $0.39 Down From $0.78 YoY, Sales $1.01B Beat $1.01B Estimate; FY21 Service Sales $3.05B-$3.15B, Adj. EBITDA $1.025B-$1.125B